메뉴 건너뛰기




Volumn 36, Issue 8, 2013, Pages 568-573

Long-term efficacy and safety of sitagliptin in the treatment of Japanese type 2 diabetes (ASSET-K1) to a target of HbA1c>7%

Author keywords

Body weight; Dipeptidyl peptidase 4 (DPP 4) inhibitor; HbA1c; Sitagliptin; Type 2 diabetes mellitus

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PIOGLITAZONE; SITAGLIPTIN; SULFONYLUREA;

EID: 84885666875     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8819     Document Type: Article
Times cited : (12)

References (21)
  • 1
    • 77954197187 scopus 로고    scopus 로고
    • Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes mellitus: A randomized double-blind trial
    • Iwamoto Y, Tajima N, Kadowaki T, et al. Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes mellitus: a randomized double-blind trial. Diabetes Obes Metab 2010, 12: 613-22.
    • (2010) Diabetes Obes Metab , vol.12 , pp. 613-622
    • Iwamoto, Y.1    Tajima, N.2    Kadowaki, T.3
  • 2
    • 38349126264 scopus 로고    scopus 로고
    • Efficacy and safety of sitaglip - Tin monotherapy in Japanese patients with type 2 diabetes
    • Nonaka K, Kakikawa T, Sato A, et al. Efficacy and safety of sitaglip - tin monotherapy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2008, 79: 291-8.
    • (2008) Diabetes Res Clin Pract , vol.79 , pp. 291-298
    • Nonaka, K.1    Kakikawa, T.2    Sato, A.3
  • 3
    • 84859016755 scopus 로고    scopus 로고
    • Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control
    • Tajima N, Kadowaki T, Odawara M, et al. Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control. Diabetol Int 2011, 2: 32-44.
    • (2011) Diabetol Int , vol.2 , pp. 32-44
    • Tajima, N.1    Kadowaki, T.2    Odawara, M.3
  • 4
    • 33846006173 scopus 로고    scopus 로고
    • GLP-1R agonists (incretin mimetics) and DPP-4 inhibitors (incretin enhancers) for the treatment of type 2 diabetes
    • Drucker DJ, Nauck MA. GLP-1R agonists (incretin mimetics) and DPP-4 inhibitors (incretin enhancers) for the treatment of type 2 diabetes. Lancet 2006, 368: 1696-705.
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 5
    • 33845344395 scopus 로고
    • Plasma insulin response to oral and intravenous glucose administration
    • Elrick H, Stimmler L, Hland CJ jr, Arai Y. Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 1964, 24: 1076-82.
    • (1964) J Clin Endocrinol Metab , vol.24 , pp. 1076-1082
    • Elrick, H.1    Stimmler, L.2    Hland Jr., C.J.3    Arai, Y.4
  • 7
    • 84355162099 scopus 로고    scopus 로고
    • ASSET-K Study group the safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes
    • Maeda H, Kubota A, Tanaka Y, Terauchi Y, Matsuba I; ASSET-K Study group. The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes. Diabetes Res Clin Pract 2012, 95: e20-2.
    • (2012) Diabetes Res Clin Pract , vol.95 , pp. 20-22
    • Maeda, H.1    Kubota, A.2    Tanaka, Y.3    Terauchi, Y.4    Matsuba, I.5
  • 8
    • 84885612196 scopus 로고    scopus 로고
    • Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
    • in press
    • Kubota A, Maeda H, Kanamori A, et al. Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients. J Diabetes Invest (in press).
    • J Diabetes Invest
    • Kubota, A.1    Maeda, H.2    Kanamori, A.3
  • 9
    • 84878065126 scopus 로고    scopus 로고
    • Pleotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients
    • Kubota A, Maeda H, Kanamori A, et al. Pleotropic effects of sitagliptin in the treatment of type 2 diabetes mellitus patients. J Clin Med Res 2012, 4: e309-13.
    • (2012) J Clin Med Res , vol.4 , pp. 309-313
    • Kubota, A.1    Maeda, H.2    Kanamori, A.3
  • 10
    • 84866268783 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A patient-centered approach position statement of the american diabetes association (ADA) and the european association for the study of diabetes (EASD)
    • Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35: 1364-79.
    • (2012) Diabetes Care , vol.35 , pp. 1364-1379
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 11
    • 78651338445 scopus 로고    scopus 로고
    • Standard of medical care in diabetes- 2011
    • American Diabetes Association
    • American Diabetes Association. Standard of medical care in diabetes- 2011. Diabetes Care 2011, 34 (Suppl. 1): S11-61.
    • (2011) Diabetes Care , vol.34 , Issue.SUPPL. 1 , pp. 11-61
  • 12
    • 79956326006 scopus 로고    scopus 로고
    • Dipeptidyl peptidase- 4 inhibitors and HbA1c target of <7% in type 2 diabetes: Meta-analysis of randomized controlled trials
    • Esposito K, Cozzolino D, Bellastella G, et al. Dipeptidyl peptidase- 4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Obes Metab 2011, 13: 594-603.
    • (2011) Diabetes Obes Metab , vol.13 , pp. 594-603
    • Esposito, K.1    Cozzolino, D.2    Bellastella, G.3
  • 13
    • 84859097891 scopus 로고    scopus 로고
    • Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan
    • Tajiri Y, Munehisa T, Ohki T, et al. Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan. Endocr J 2012, 59: e197-204.
    • (2012) Endocr J , vol.59 , pp. 197-204
    • Tajiri, Y.1    Munehisa, T.2    Ohki, T.3
  • 14
    • 0032856829 scopus 로고    scopus 로고
    • Heterogeneous relationship of early insulin response and fasting insulin level with development of noninsulin- dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity
    • Yoshinaga H, Kosaka K. Heterogeneous relationship of early insulin response and fasting insulin level with development of noninsulin- dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract 1999, 44: 129-36.
    • (1999) Diabetes Res Clin Pract , vol.44 , pp. 129-136
    • Yoshinaga, H.1    Kosaka, K.2
  • 15
    • 77954731903 scopus 로고    scopus 로고
    • Present status of sulfonylurea treatment for type 2 diabetes in Japan: Second report of a cross-sectional survey of 15,652 patients
    • Arai K, Matoba K, Hirao K, et al. Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients. Endocr J 2010, 57: 499-507.
    • (2010) Endocr J , vol.57 , pp. 499-507
    • Arai, K.1    Matoba, K.2    Hirao, K.3
  • 16
    • 84867752550 scopus 로고    scopus 로고
    • Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels
    • Iwasaki M, Hoshian F, Tsuji T, et al. Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels. J Diabetes Invest 2012, 3: 464-7.
    • (2012) J Diabetes Invest , Issue.3 , pp. 464-467
    • Iwasaki, M.1    Hoshian, F.2    Tsuji, T.3
  • 17
    • 0032812996 scopus 로고    scopus 로고
    • Food intake patterns and 25-year mortality from coronary heart disease: Cross-cultural correlations in the Seven Countries Study
    • The Seven Countries Study Research Group
    • Menotti A, Kromhout D, Blackburn H, et al. Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group. Eur J Epidemiol 1999, 15: 507-15.
    • (1999) Eur J Epidemiol , vol.15 , pp. 507-515
    • Menotti, A.1    Kromhout, D.2    Blackburn, H.3
  • 18
    • 48449093468 scopus 로고    scopus 로고
    • Separate impact of obesity and glucose tolerance on the incretin effect in normal subject and type 2 diabetic patients
    • Muscelli E, Mari A, Casolaro A, et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subject and type 2 diabetic patients. Diabetes 2008, 57: 1340-8.
    • (2008) Diabetes , vol.57 , pp. 1340-1348
    • Muscelli, E.1    Mari, A.2    Casolaro, A.3
  • 19
    • 40949090627 scopus 로고    scopus 로고
    • Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance
    • Vollmer K, Holst JJ, Baller B, et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008, 57: 678-87.
    • (2008) Diabetes , vol.57 , pp. 678-687
    • Vollmer, K.1    Holst, J.J.2    Baller, B.3
  • 20
    • 79952310049 scopus 로고    scopus 로고
    • Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: What is up, what is down?
    • Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011, 54: 10-8.
    • (2011) Diabetologia , vol.54 , pp. 10-18
    • Nauck, M.A.1    Vardarli, I.2    Deacon, C.F.3    Holst, J.J.4    Meier, J.J.5
  • 21
    • 58149467276 scopus 로고    scopus 로고
    • Four weeks of near-normalisation of blood glucose improves the insulin response to glucagonlike peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
    • Højberg PV, Vilsbøll T, Rabøl R, et al. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagonlike peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia 2009, 52: 199-20.
    • (2009) Diabetologia , vol.52 , pp. 199-130
    • Højberg, P.V.1    Vilsbøll, T.2    Rabøl, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.